Patent · US Active

Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis

US9956250B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignees

Inventors

Wei CAO · Shanghai, CN
Xiaoling ZENG · Shanghai, CN
Mohammad Abdul Kaium · Shanghai, CN
Yujie Zhou · Shanghai, CN

Key dates

Filing date	Jan 28, 2014
Grant date	May 1, 2018
Priority date	—
Expiry date	Jan 28, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are uses of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells in the preparation of a pharmaceutical composition for preventing or treating osteoarthritis (OA). Also provided is a pharmaceutical composition containing the allogeneic interstitial vessel-layer cells and the allogeneic mesenchymal progenitor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.